The estimated Net Worth of Fred B Craves is at least $313 Milion dollars as of 14 May 2024. Frederick Craves owns over 22,489 units of Madrigal Pharmaceuticals Inc stock worth over $101,553,283 and over the last 21 years he sold MDGL stock worth over $210,345,000. In addition, he makes $657,500 as Lead Independent Director at Madrigal Pharmaceuticals Inc.
Frederick has made over 9 trades of the Madrigal Pharmaceuticals Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 22,489 units of MDGL stock worth $2,316,817 on 14 May 2024.
The largest trade he's ever made was selling 1,200,000 units of Madrigal Pharmaceuticals Inc stock on 13 December 2019 worth over $126,564,000. On average, Frederick trades about 48,224 units every 103 days since 2004. As of 14 May 2024 he still owns at least 435,851 units of Madrigal Pharmaceuticals Inc stock.
You can see the complete history of Frederick Craves stock trades at the bottom of the page.
Dr. Frederick B. Craves Ph.D. serves as Lead Independent Director of the Company. Dr. Craves co-founded and served as Chairman of the Board of Private Madrigal, a privately-held biopharmaceutical company, from its inception in September 2011 through the Merger involving Synta, in July of 2016. Dr. Craves is a Managing Director and co-founder of Bay City Capital. In the course of his career, Dr. Craves has founded and managed several biotechnology companies. Dr. Craves previously served on the boards of directors of several privately-held and publicly-held companies. Dr. Craves currently serves as a member of the board of directors of Synchronicity Pharma, Inc., Imidomics, Inc., and KBP Pharmaceuticals, Inc., each a privately-held life science company. During the past five years, Dr. Craves served as a member of the board of directors of Dermira, Inc. and Twist Bioscience, Inc., each a publicly-held life science company. Dr. Craves earned a B.S. degree in biology from Georgetown University, an M.S. in biochemical pharmacology from Wayne State University and a Ph.D. in pharmacology and experimental toxicology from the University of California, San Francisco.
As the Lead Independent Director of Madrigal Pharmaceuticals Inc, the total compensation of Frederick Craves at Madrigal Pharmaceuticals Inc is $657,500. There are 13 executives at Madrigal Pharmaceuticals Inc getting paid more, with Paul Friedman having the highest compensation of $6,093,190.
Frederick Craves is 74, he's been the Lead Independent Director of Madrigal Pharmaceuticals Inc since 2016. There are 2 older and 14 younger executives at Madrigal Pharmaceuticals Inc. The oldest executive at Madrigal Pharmaceuticals Inc is David Milligan, 79, who is the Independent Director.
Fred's mailing address filed with the SEC is C/O BAY CITY CAPITAL LLC,, 1000 4TH STREET, SUITE 500, SAN RAFAEL, CA, 94901.
Over the last 8 years, insiders at Madrigal Pharmaceuticals Inc have traded over $471,222,585 worth of Madrigal Pharmaceuticals Inc stock and bought 443,785 units worth $79,114,183 . The most active insiders traders include Bros. Advisors Lp667, L.P.B..., Paul A Friedman oraz Bros. Advisors Lp667, L.P.B.... On average, Madrigal Pharmaceuticals Inc executives and independent directors trade stock every 56 days with the average trade being worth of $20,602,093. The most recent stock trade was executed by William John Sibold on 9 September 2024, trading 6,363 units of MDGL stock currently worth $1,551,490.
madrigal pharmaceuticals inc. is a biotechnology company based out of calle laguna del marquesado nª 19, nave 16 edificio adriana 1ª planta, polígono industrial la resina (villaverde), madrid, community of madrid, spain.
Madrigal Pharmaceuticals Inc executives and other stock owners filed with the SEC include: